Search research articles
Contact Us
Filters
Showing results (671-680 of 751) with videos related to
Page
of 76
Sort By:
American Heart Journal
|
May 9, 2022
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial
Warren J Cantor, Mary Tan, Otavio Berwanger, et al.
JAMA Cardiology
|
September 29, 2018
Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial
Renato D Lopes, Pedro G M de Barros E Silva, Isabella de Andrade Jesuíno, et al.
Journal of Cardiac Failure
|
April 18, 2025
NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial
Karola S Jering, Brian L Claggett, Eugene Braunwald, et al.
Lancet (London, England)
|
June 17, 2014
Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial
L Kristin Newby, Michael S Marber, Chiara Melloni, et al.
Journal of the American Heart Association
|
November 26, 2020
Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines-Atrial Fibrillation
Frederik Dalgaard, Haolin Xu, Roland A Matsouaka, et al.
Journal of the American College of Cardiology
|
February 28, 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI
Douglas L Mann, Johny Nicolas, Brian Claggett, et al.
NEJM Evidence
|
May 26, 2026
Patient-Centered Evaluation of Anticoagulation in Atrial Fibrillation
Satoshi Shoji, Pishoy Gouda, Caroline A Falvey, et al.
Journal of Cardiac Failure
|
April 24, 2022
Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial
Bradi B Granger, Lisa A Kaltenbach, Gregg C Fonarow, et al.
Circulation. Heart Failure
|
December 10, 2019
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction
Pooja Dewan, Rasmus Rørth, Valeria Raparelli, et al.
Lancet (London, England)
|
October 6, 2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial
Renato D Lopes, Sana M Al-Khatib, Lars Wallentin, et al.
Page
of 76
Search research articles
Search
Showing results (671-680 of 751) with videos related to
Sort By:
Page
of 76
American Heart Journal
|
May 9, 2022
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial
Warren J Cantor, Mary Tan, Otavio Berwanger, et al.
JAMA Cardiology
|
September 29, 2018
Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial
Renato D Lopes, Pedro G M de Barros E Silva, Isabella de Andrade Jesuíno, et al.
Journal of Cardiac Failure
|
April 18, 2025
NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial
Karola S Jering, Brian L Claggett, Eugene Braunwald, et al.
Lancet (London, England)
|
June 17, 2014
Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial
L Kristin Newby, Michael S Marber, Chiara Melloni, et al.
Journal of the American Heart Association
|
November 26, 2020
Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines-Atrial Fibrillation
Frederik Dalgaard, Haolin Xu, Roland A Matsouaka, et al.
Journal of the American College of Cardiology
|
February 28, 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI
Douglas L Mann, Johny Nicolas, Brian Claggett, et al.
NEJM Evidence
|
May 26, 2026
Patient-Centered Evaluation of Anticoagulation in Atrial Fibrillation
Satoshi Shoji, Pishoy Gouda, Caroline A Falvey, et al.
Journal of Cardiac Failure
|
April 24, 2022
Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial
Bradi B Granger, Lisa A Kaltenbach, Gregg C Fonarow, et al.
Circulation. Heart Failure
|
December 10, 2019
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction
Pooja Dewan, Rasmus Rørth, Valeria Raparelli, et al.
Lancet (London, England)
|
October 6, 2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial
Renato D Lopes, Sana M Al-Khatib, Lars Wallentin, et al.
Page
of 76